000 | 01480 a2200385 4500 | ||
---|---|---|---|
005 | 20250513074527.0 | ||
264 | 0 | _c19930210 | |
008 | 199302s 0 0 eng d | ||
022 | _a0006-3002 | ||
024 | 7 |
_a10.1016/0005-2760(93)90145-y _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGiroux, L M | |
245 | 0 | 0 |
_aSimvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages. _h[electronic resource] |
260 |
_bBiochimica et biophysica acta _cJan 1993 |
||
300 |
_a335-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxymethylglutaryl CoA Reductases _xpharmacology |
650 | 0 | 4 | _aHydroxymethylglutaryl-CoA Reductase Inhibitors |
650 | 0 | 4 |
_aLipoproteins, LDL _xmetabolism |
650 | 0 | 4 |
_aLovastatin _xanalogs & derivatives |
650 | 0 | 4 | _aMacrophage Activation |
650 | 0 | 4 |
_aMacrophages _xdrug effects |
650 | 0 | 4 |
_aMevalonic Acid _xpharmacology |
650 | 0 | 4 |
_aMonocytes _xdrug effects |
650 | 0 | 4 |
_aOxidation-Reduction _xdrug effects |
650 | 0 | 4 | _aSimvastatin |
650 | 0 | 4 |
_aSuperoxides _xmetabolism |
650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xpharmacology |
700 | 1 | _aDavignon, J | |
700 | 1 | _aNaruszewicz, M | |
773 | 0 |
_tBiochimica et biophysica acta _gvol. 1165 _gno. 3 _gp. 335-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0005-2760(93)90145-y _zAvailable from publisher's website |
999 |
_c8379611 _d8379611 |